ANIP - Slight Up ChannelA slight up channel has appeared in the larger overarching down channel.
If this channel takes dominance we could see a price rise.
This price rise is plotted with the bars pattern tool.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.5EUR
17.01 MEUR
441.06 MEUR
17.21 M
About ANI Pharmaceuticals, Inc.
Sector
Industry
CEO
Nikhil Lalwani
Website
Headquarters
Baudette
Employees (FY)
642
Founded
1996
FIGI
BBG000FWNL00
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Is ready for 77?I think is ready to liftoff with positive divergence but there is a possibility of another drop on the green line.
Bye, Bye, mANIPulationSold 750 shares of ANIP
$22,329 back into my Account.
We will see where it closes the day (?)
But, I would rather have the Money!
mANIPulation"They" put me thru a lot of Angst!
But, I collected 750 shares of: ANIP .
$27.85 = Profitable.
ANIP 4daily 150% gains(STOCKS)before we kick start the update. your upvotes/subs are appreciated.
Why get subbed to to me on Tradingview?
-15+ years real live trading experience
-TOP Author on TradingView
-professional chart break downs
-key levels
-no junk on my charts
-frequent updates
-covering FX/crypto/US stocks
-24/7
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate ANIP: ANI Pharmaceuticals, Inc.
2020-01-16 08:30:00
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
ANIP reviewThis is a review of my previous chart setup. Basically a break even trade. I wouldn’t hold on to this stock anymore but you can if you think otherwise. That’s it
ANIP Triangle formation Two consecutive green candles that closed higher than the last. That’s why I’m going long on this one
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ANI PHARMACEUT. DL-,0001 stocks are traded under the ticker BSFA.
We've gathered analysts' opinions on ANI PHARMACEUT. DL-,0001 future price: according to them, BSFA price has a max estimate of 79.95 EUR and a min estimate of 70.76 EUR. Watch BSFA chart and read a more detailed ANI PHARMACEUT. DL-,0001 stock forecast: see what analysts think of ANI PHARMACEUT. DL-,0001 and suggest that you do with its stocks.
BSFA reached its all-time high on Jul 31, 2019 with the price of 75.5 EUR, and its all-time low was 0.5 EUR and was reached on Jul 22, 2013. View more price dynamics on BSFA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track ANI PHARMACEUT. DL-,0001 financials in yearly and quarterly reports right on TradingView.
ANI PHARMACEUT. DL-,0001 is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
BSFA earnings for the last quarter are 1.12 EUR per share, whereas the estimation was 0.92 EUR resulting in a 21.49% surprise. The estimated earnings for the next quarter are 0.89 EUR per share. See more details about ANI PHARMACEUT. DL-,0001 earnings.
ANI PHARMACEUT. DL-,0001 revenue for the last quarter amounts to 127.37 M EUR despite the estimated figure of 116.80 M EUR. In the next quarter revenue is expected to reach 119.82 M EUR.
BSFA net income for the last quarter is 15.20 M EUR, while the quarter before that showed 1.05 M EUR of net income which accounts for 1.35 K% change. Track more ANI PHARMACEUT. DL-,0001 financial stats to get the full picture.
No, BSFA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 25, 2024, the company has 642.00 employees. See our rating of the largest employees — is ANI PHARMACEUT. DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANI PHARMACEUT. DL-,0001 EBITDA is 104.97 M EUR, and current EBITDA margin is 22.46%. See more stats in ANI PHARMACEUT. DL-,0001 financial statements.
Like other stocks, BSFA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANI PHARMACEUT. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.